You act as a paraphrase tool. Your role involves understanding the provided text…
- User
System: You act as a paraphrase tool. Your role involves understanding the provided text and then providing a positive example that keeps the original meaning of the text unchanged while using synonyms, interchanging, adding or removing words or sentences, and then provide a negative example where the meaning of the original text is at its opposite. Output your response with the following format : Positive : Negative :
User: We may rely on contract research organizations, or CROs, to perform preclinical testing and clinical trials for drug candidates that we choose to develop without a collaborator. If the CROs that we hire to perform our preclinical testing and clinical trials or our collaborators or licensees do not meet deadlines, do not follow proper procedures or a conflict arises between us and our CROs, our preclinical testing and clinical trials may take longer than expected, may be delayed or may be terminated. If we were forced to find a replacement CRO to perform any of our preclinical testing or clinical trials, we may not be able to find a suitable replacement on favorable terms, if at all. Even if we were able to find another CRO to perform a preclinical test or clinical trial, any material delay in a test or clinical trial may result in significant additional expenditures that could adversely affect our operating results. Events such as these may also delay regulatory approval for our drug candidates or our ability to commercialize our products. We depend on clinical investigators and clinical sites to enroll patients in our clinical trials and sometimes other third parties to manage the trials and to perform related data collection and analysis, and, as a result, we may face costs and delays outside of our control. We rely on clinical investigators and clinical sites Assistant:
- Assistant
Positive: We might depend on contract research organizations (CROs) to carry out the preclinical tests and clinical trials for the drug candidates we decide to advance without partners. If the CROs we engage for our testing or if any associates or licensees fail to meet deadlines, don't adhere to correct protocols, or conflicts occur between us and our CROs, our testing and clinical trials might be extended, postponed, or even terminated. Should we need to replace a CRO for conducting our tests or trials, finding a suitable substitute on beneficial terms might prove challenging or impossible. Though we might locate another CRO, substantial delays in any test or trial could lead to significant extra costs, potentially harming our operating outcomes. Such issues might also postpone regulatory approval for our drug candidates or hinder our ability to bring our products to market. We depend on clinical investigators and sites to recruit patients into our trials and occasionally other third parties for trial management and the associated data collection and analysis, potentially leading to unforeseen expenses and delays.
Negative: We have no reliance on contract research organizations or CROs for conducting preclinical testing or clinical trials for our drug candidates. Even if the CROs we employ do not meet deadlines, follow the proper procedures, or if disputes occur between us and our CROs, it will neither delay nor terminate our preclinical testing and clinical trials. If we were required to find a new CRO, we would easily secure a suitable, cost-effective alternative. Even with significant delays, no extra expenses would impact our operating results, and there would be no effect on regulatory approval or commercialization timelines for our products. We do not depend on clinical investigators or sites for trial participant enrollment and have no potential cost or delay risks that are beyond our control.